PLURISTEM THERAPEUTICS INC 4
4 · PLURISTEM THERAPEUTICS INC · Filed Feb 16, 2016
Insider Transaction Report
Form 4
Aberman Zami
DirectorCEO & Co. Chairman
Transactions
- Purchase
Common Stock
2016-02-11$0.80/sh+31,000$24,716→ 91,400 total(indirect: By Rose Hitech Ltd.)
Holdings
- 2,118,298
Common Stock
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.7798 to $0.8105, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the above range.